Published in BMJ on February 17, 1996
Survey illustrates misconception of the Calman proposals. BMJ (1995) 1.08
Attitudes of consultant physicians to Calman proposals. Proposals do not refer to need for consultant provided service. BMJ (1995) 1.07
Attitudes of consultant physicians to Calman proposals. Royal College of Physicians gave qualified support to proposals. BMJ (1995) 0.91
The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. Br Med J (Clin Res Ed) (1985) 6.36
The Oxford Community Diabetes Study: evidence for an increase in the prevalence of known diabetes in Great Britain. Diabet Med (1988) 2.03
High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med (1992) 1.66
Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects. Diabetologia (2000) 1.54
The Eluru survey: prevalence of known diabetes in a rural Indian population. Diabetes Res Clin Pract (1989) 1.50
Effect of oestrogens on human platelet behaviour. Lancet (1968) 1.49
Helicobacter pylori infection and upper gastrointestinal patholgy in a British immigrant Indian community. Eur J Gastroenterol Hepatol (1997) 1.42
Serum sialic acid concentrations in Asian diabetic patients in the UK. Diabet Med (1996) 1.40
Assessment of simple colorimetric procedures to determine smoking status of diabetic subjects. Clin Chem (1998) 1.40
Hyperkalaemia and apple juice. Lancet (2001) 1.39
Hypomagnesaemia in diabetes. Clin Chim Acta (1979) 1.31
Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. Br Med J (Clin Res Ed) (1988) 1.29
The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control. Diabetes Care (1998) 1.28
Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diabetes Care (1999) 1.23
Effect of treatment of hyperlipidaemia on haemostatic variables. Br Med J (1980) 1.20
Variability in vibration perception threshold among sites: a potential source of error in biothesiometry. Br Med J (Clin Res Ed) (1988) 1.19
Evaluation of a non-mydriatic camera in Indian and European diabetic patients. Br J Ophthalmol (1988) 1.19
Prevalence of known diabetes in an urban Indian environment: the Darya Ganj diabetes survey. Br Med J (Clin Res Ed) (1986) 1.19
Effects of smoking on oral fat tolerance and high density lipoprotein cholesterol. Clin Sci (Lond) (1983) 1.18
The scope for cardiovascular disease risk factor intervention among people with diabetes mellitus in England: a population-based analysis from the Health Surveys for England 1991-94. Diabet Med (1999) 1.12
Asian diabetes in Britain: a clinical profile. Diabet Med (1986) 1.11
Factors predisposing to and outcome of gestational diabetes. Obstet Gynecol (1989) 1.10
Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis (2001) 1.06
Hyperkalaemia in diabetes: prevalence and associations. Postgrad Med J (1995) 1.04
Hypoglycaemia in an inner-city accident and emergency department: a 12-month survey. Arch Emerg Med (1989) 1.04
Impaired intravascular lipolysis with changes in concentrations of high density lipoprotein subclasses in young smokers. Br Med J (Clin Res Ed) (1987) 1.03
Serum lipids, lipoproteins and macrovascular disease in non-insulin-dependent diabetics: a possible new approach to prevention. Diabet Med (1988) 1.00
The effect of diet and insulin on metabolic profiles of women with gestational diabetes mellitus. Diabetes (1985) 0.99
Vasopressin in plasma and CSF of patients with subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1981) 0.99
Severe envenomation from "harmless" pet snake. Br Med J (1978) 0.97
Insulin resistance in patients of Asian Indian and European origin with non-insulin dependent diabetes. Horm Metab Res (1987) 0.96
Vasopressin in human cerebrospinal fluid. J Clin Endocrinol Metab (1980) 0.95
The effect of heparin in vitro on human plasm post-heparin lipolytic activity. Clin Chim Acta (1975) 0.95
Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care (2000) 0.93
Effect of a pyrimido-pyrimidine compound on platelet behaviour in vitro and in vivo. Lancet (1968) 0.92
Desmopressin and desglycinamide vasopressin in post-traumatic amnesia. Lancet (1981) 0.92
Total antioxidant status and coronary artery calcification in type 1 diabetes. Diabetes Care (2001) 0.90
The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes. Diabet Med (1991) 0.90
Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects. J Hum Hypertens (1990) 0.89
Effect of treatment of hypertriglyceridaemia on high and low density lipoprotein cholesterol concentrations. Lancet (1979) 0.87
Tissue magnesium status in diabetes mellitus. Diabetologia (1981) 0.87
High-density lipoprotein composition and paraoxonase activity in Type I diabetes. Clin Sci (Lond) (2001) 0.87
Evidence for an hepatic anti-ketogenic effect of insulin in man. Clin Sci Mol Med (1978) 0.86
Beta-blockers, lipoproteins and non-insulin dependent diabetes. Postgrad Med J (1988) 0.85
Calorie restriction for treatment of gestational diabetes. Diabetes (1991) 0.85
Type 2 diabetes presenting as diabetic ketoacidosis in adolescence. Diabet Med (2003) 0.84
Diurnal profiles of plasma magnesium and blood glucose in diabetes. Diabetologia (1982) 0.84
Heroin and hyperkalaemia. Lancet (1981) 0.84
The effect of insulin on adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate concentrations in human plasma. Clin Sci Mol Med (1976) 0.84
Serum-insulin in acromegaly. Lancet (1969) 0.83
Lipids in non-insulin dependent diabetes: a case for treatment? J R Soc Med (1991) 0.82
Ethnic minorities in British diabetic clinics: a questionnaire survey. Diabet Med (1987) 0.82
The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes. Diabet Med (1988) 0.82
Lipoprotein lipase in human adipose tissue. Clin Sci Mol Med (1974) 0.82
Arterial wall changes in type 2 diabetic subjects. Diabet Med (1994) 0.82
Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes. Clin Sci (Lond) (1998) 0.81
Total antioxidant status, protein glycation, lipid hydroperoxides in non insulin dependent diabetes mellitus. Biochem Soc Trans (1997) 0.81
Prostaglandin E 1 and human platelets. Lancet (1969) 0.81
Magnesium status in diabetes. Lancet (1979) 0.81
Abnormalities of glucose tolerance following gestational diabetes. Q J Med (1990) 0.81
Can protein biomarkers provide an index of coronary artery calcification in patients with Type 2 diabetes? Atherosclerosis (2010) 0.81
Lipid modification and coronary heart disease in type 2 diabetes: different from the general population? Heart (1999) 0.81
Hepatic and lipoprotein lipases selectively assayed in postheparin plasma. Clin Chem (1993) 0.80
High density lipoproteins, diabetes and diabetic macrovascular disease. Diabet Med (1985) 0.80
Rates of cholesterol esterification and esterified cholesterol net mass transfer between high-density lipoproteins and apolipoprotein B-containing lipoproteins in Type 1 diabetes. Diabet Med (2002) 0.80
Correlation between carotid artery distensibility and serum vascular endothelial growth factor concentrations in type 1 diabetic subjects and nondiabetic subjects. Metabolism (2001) 0.79
Plasma adenosine 3':5'-cyclic monophosphate response to glucagon in thyroid disease. Clin Sci Mol Med (1975) 0.79
Heart size and function in acromegaly. Br Heart J (1979) 0.79
Diabetic hypertension--the importance of fibrinogen and blood viscosity. J Hum Hypertens (1988) 0.78
Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study. Diabet Med (2006) 0.78
Effect of the aldose reductase inhibitor, ponalrestat, on diabetic neuropathy. Diabete Metab (1991) 0.78
The effects of fasting and streptozotocin diabetes on hepatic triglyceride lipase activity in the rat. Diabetes (1977) 0.78
The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal. Diabetologia (1978) 0.78
The effect of hypolipidaemic therapy on serum uric acid concentration. Atherosclerosis (1976) 0.78
The relationship between active renin concentration and plasma renin activity in Type 1 diabetes. Diabet Med (2001) 0.78
Hypertriglyceridaemia and hyperuricaemia. Lancet (1977) 0.77
Higher serum sialic acid in women than in men with NIDDM: possible relevance to increased cardiovascular risk in NIDDM women. Diabetes Care (1997) 0.77
Treatment of diabetes: the effect on serum lipids and lipoproteins. Postgrad Med J (1991) 0.77
Analysis of high density lipoprotein subclasses by a precipitation procedure: comparison with preparative ultracentrifuge. Clin Chim Acta (1982) 0.77
Aspects of metabolism in normal and gestational diabetic pregnancy. Biochem Soc Trans (1995) 0.77
Serum insulin, glucose, and lipid levels among mild diabetics in relation to incidence of vascular complications. Lancet (1971) 0.77
The prevalence of known diabetes in Indians in New Delhi and London. J Med Assoc Thai (1987) 0.77
Abnormalities in fasting circulating proinsulin concentration in mild gestational diabetes. Clin Endocrinol (Oxf) (1991) 0.76
A defect in insulin release in women at risk of future non-insulin-dependent diabetes. Clin Sci (Lond) (1991) 0.76
Desmopressin in post-traumatic amnesia. Lancet (1979) 0.76
Serum lipids and apolipoproteins and their relationship with macrovascular disease in type 1 diabetes. Diabet Med (1994) 0.76
Feedback inhibition of insulin secretion in type 2 diabetes. Clin Sci (Lond) (1991) 0.76
Determinants of mild fasting hypertriglyceridaemia in non-insulin-dependent diabetes. J Intern Med (1991) 0.76
Regulation of hepatic lipase expression in HepG2 cells. Biochem Soc Trans (1997) 0.76
Chlorpropamide lowers serum and lipoprotein cholesterol in insulin-dependent diabetes. Diabet Med (1986) 0.76
The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy. J R Soc Med (1989) 0.76
Reduced postprandial energy expenditure in women predisposed to type 2 diabetes. Diabet Med (1994) 0.76
Ethnic differences in insulin secretion in women at risk of future diabetes. Diabet Med (1992) 0.76
The effect of treatment of non-insulin-dependent diabetes mellitus (NIDDM) on serum lipids and lipoproteins. Q J Med (1989) 0.75
Insulin and atheroma. Lancet (1969) 0.75
Effect of desmopressin on normal and impaired memory. J Neurol Neurosurg Psychiatry (1982) 0.75
Management of hyperosmolar coma. J R Soc Med (1980) 0.75
Occult spontaneous intramuscular haemorrhage as a complication of heparin for unstable angina. Postgrad Med J (1991) 0.75
Acute lipoprotein changes associated with atenolol therapy for hypertension in non-insulin dependent diabetes. J Hum Hypertens (1988) 0.75